CDN1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 103 | |
4 mg | In stock | $ 185 | |
8 mg | In stock | $ 277 | |
20 mg | In stock | $ 475 | |
40 mg | In stock | $ 717 |
Description | CDN1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). |
In vivo | CDN1163, which markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight in lean controls.?Importantly, CDN1163-treated ob/ob mice maintained euglycemia comparable with that of lean mice for >6 weeks after cessation of CDN1163 administration. |
CAS No. | 892711-75-0 |
Chemical Formula | C20H20N2O2 |
Molecular Weight | 320.392 |
Solubility | DMSO: 50 mg/mL (156.06 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom